Hence, LSD1 inhibitors exhibit antitumor effects by derepressing ERV factors, activating type I IFN expression, activating CD8+ T cells, facilitating infiltration in cancer tissues, and promoting DC differentiation in melanoma147. Here, KDM1A is linked to cancer.